To study the effect of Panchavalkala Kwatha(an Ayurvedic Formulation) in patients having Irritable bowel syndrome

Pharmaco-clinical study of Panchavalkala Kwatha with special reference to Sangrahani(Irritable Bowel Syndrome) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081961

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the classical signs and symptoms of Samgrahagrahani roga Patients diagnosed as IBS ROME 4 criteria

Exclusion criteria

Exclusion criteria: 1 Not willing to complete consent process as describes in proforma 2 Diagnosed cases of Inflammatory bowel disease 3 Colonic neoplasm 4 Acute gastrointestinal conditions and bleeding per rectum 5 Patients with other serious systemic diseases 6 Pregnant or lactating women 7 History of previous gastric surgery

Design outcomes

Primary

Measure	Time frame
1.IBS Symptom Severity Score(IBS-SSS)-TOTAL SCORE RANGES FROM 0 TO 5OO.A decrease of 50 points correlated with improvement in clinical symptoms 2.Decrease in the clinical signs and symptoms of Sangrahani rogaTimepoint: Baseline,15 th,30 th,45 th,60 th,75 th and 90 th day	—

Secondary

Measure	Time frame
Improvement in WHO IBS 36 -Quality of life scoreTimepoint: Analysed as a total score before (day 0)and after(day 90)of trial	—

Countries

India

Contacts

Public ContactProf Anil Kumar Singh

Banaras Hindu University

anilk.singh@bhu.ac.in9415651966

Outcome results